AcelRx Pharmaceuticals Inc (ACRX) stock is lower by -7.80% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ACRX stock a score of 77 out of a possible 100.
That rank is primarily influenced by a long-term technical score of 96. ACRX's rank also includes a fundamental score of 87. In addition to the average rating from Wall Street analysts, ACRX stock has a mean target price of 6. This means analysts expect the stock to increase 198.51% over the next 12 months. The short-term technical score for ACRX is 48.
What's Happening with ACRX Stock Today
AcelRx Pharmaceuticals Inc (ACRX) stock is up 1.52% while the S&P 500 is lower by -0.38% as of 1:10 PM on Tuesday, Oct 13. ACRX has gained $0.03 from the previous closing price of $1.98 on volume of 1,177,002 shares. Over the past year the S&P 500 is up 18.70% while ACRX is lower by -7.80%. ACRX lost -$0.62 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on AcelRx Pharmaceuticals Inc (ACRX) Stock.
